Poonam Kumari Opposition, Lenacapavir, (201917006277)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
LOW COST STANDARD THERAPEUTICS opposition, TAF/FTC, (201817001590)
Countries: India Date: 2023
-
Thai Network of People Living with HIV/AIDS (TNP+) opposition, Lenacapavir, (WO/2014/134566)
Countries: Thailand Date: 2023
-
Balaji R opposition, Elexacaftor, (201737015848)
Countries: India Date: 2023
-
Sankalp Rehabilitation Trust opposition, Quabodepistat, (201737004817)
Countries: India Date: 2023
-
Sankalp Rehabilitation Trust opposition, Bedaquiline Long Acting, (202017005443)
Countries: India Date: 2023
-
Mylan Laboratories India opposition, Raltegravir, (4187/DELNP/2007)
Countries: India Date: 2018
-
Delhi Network of Positive People opposition, Lenacapavir, (201917006277)
Countries: India Date: 2021
-
Sankalp Rehabilitation Trust opposition, Lenacapavir, (202017010006)
Countries: India Date: 2021
-
Sankalp Rehabilitation Trust opposition, Lenacapavir, (202017007904)
Countries: India Date: 2021
-
Sankalp Rehabilitation Trust opposition, Lenacapavir, (7440/DELNP/2015)
Countries: India Date: 2021